Investigation of incidence and risk factors of subcutaneous granulomas induced by injection of leuprorelin acetate

Acta Urologica Japonica

Volumn 61, Issue 2, 2015, Pages 55-59

  Fukui, Shinji ^a   Nakai, Yasushi ^a   Matsumoto, Yoshihiro ^a   Kagebayashi, Yoriaki ^a   Samma, Shoji ^a  

^a Nara Prefecture General Medical Center   (Japan)

Author keywords

Leuprorelin acetate; Prostate cancer; Subcutaneous granuloma

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; LEUPRORELIN;

AGED; CHEMICALLY INDUCED; GRANULOMA; HUMAN; INCIDENCE; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK FACTOR; SUBCUTANEOUS DRUG ADMINISTRATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; GRANULOMA; HUMANS; INCIDENCE; INJECTIONS, SUBCUTANEOUS; LEUPROLIDE; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84926034005     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Shiota M, Tokuda N, Kanou T, et al.: Incidence rate of injection-site granulomas resulting from the administration of luteinizing hormone-releasing hormone analogues for the treatment of prostatic cancer. Yonsei Med J 48: 421-424, 2007
2. MB Derma 204: 45-51, 2013
3. Manasco P: Local reactions to depot leuprolide therapy for central precocious puberty. J Pediatr 123: 334-335, 1993
4. Neely EK, Hintz RL, Parker B, et al.: Two-year results of treatment with depot leuprolide acetate for central precocious puberty. J Pediatr 121: 634-640, 1992
5. Tonini G, Marinoni S, Forleo V, et al.: Local reactions to luteinizing hormone releasing hormone analog therapy. J Pediatr 126: 159-160, 1995
6. Shiota M, Tokuda N, Kanou T, et al.: Injection-site granulomas resulting from the administration of both leuprorelin acetate and goserelin acetate for the treatment of prostatic cancer. J Nippon Med Sch 74: 306-308, 2007